FINAL - October 23, 2023

8:00 Welcome & Introductions Dr. Grace Lee (ACIP Chair)

Dr. Melinda Wharton (ACIP Executive Secretary, CDC)

8:30 Meningococcal Vaccines

Introduction

Plan for revisiting adolescent schedule for meningococcal vaccines

Comparison of Pfizer and CDC cost effectiveness analyses

Summary of EtR and proposed recommendations for Pfizer’s 

MenABCWY vaccine 

Vaccines for Children Resolution

Dr. Kathy Poehling (ACIP, WG Chair)

Dr. Lucy McNamara (CDC/NCIRD)

Dr. Ismael Ortega-Sanchez (CDC/NCIRD)

Dr. Jennifer Collins (CDC/NCIRD)

Dr. Jeanne Santoli (CDC/NCIRD)

10:10 Break

10:25 Mpox Vaccines

Introduction

Updates about U.S. mpox epidemiology, vaccine safety, and vaccine 

effectiveness

Evidence to recommendations framework

Review of voting language and clinical guidance

Vaccines for Children resolution

Dr. Pablo Sanchez (ACIP, WG Chair)

Dr. Faisal Minhaj (CDC/NCEZID)

Dr. Agam Rao (CDC/NCEZID)

Dr. Agam Rao (CDC/NCEZID)

Dr. Jeanne Santoli (CDC/NCIRD)

12:15 Break

12:45 Public Comment

1:00 VOTES

Meningococcal Vote

Meningococcal VFC Vote

Mpox Vote

Mpox VFC Vote

Dr. Jennifer Collins (CDC/NCIRD)

Dr. Jeanne Santoli (CDC/NCIRD)

Dr. Agam Rao (CDC/NCEZID)

Dr. Jeanne Santoli (CDC/NCIRD)

1:30 Break

1:45 RSV - Adults

Introduction

GSK safety and immunogenicity in persons 50-59 years of age

Epidemiology of RSV in adults

Work group interpretation and ACIP discussion

Dr. Camille Kotton (ACIP, WG Chair)

Dr. Susan Gerber (GSK)

Dr. Monica Patton (CDC/NCIRD)

Dr. Amadea Britton (CDC/NCIRD)

3:00 Influenza Vaccines

Introduction

Safety of quadrivalent recombinant influenza vaccine in pregnant 

women and their infants

Pregnancy outcomes with ccIIV4 (Flucelvax): results of a postmarketing study

Safety of simultaneous versus sequential administration of mRNA 

COVID-19 and Quadrivalent Inactivated Influenza (IIV4) Vaccines: 

A randomized placebo controlled trial

Safety of simultaneous vaccination with Zoster Vaccine Recombinant 

(RZV) and quadrivalent Adjuvanted Inactivated Influenza Vaccine 

(allV4)

Dr. Jamie Loehr (ACIP, WG Chair)

Dr. Nicky Klein (Kaiser Permanente Northern California)

Dr. Gregg Sylvester (Seqirus)

Dr. Chip Walter (Duke University)

Dr. Ken Schmader (Duke University)

4:30 Vaccine Safety Update

Update on COVID-19 and Influenza Vaccine Safety Dr. Tom Shimabukuro (CDC/NCEZID)

5:30 Adjourn

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

Atlanta, Georgia 30329 

October 25-26, 2023

Wednesday, October 25, 2023
FINAL - October 23, 2023

8:00 Welcome & Introductions Dr. Grace Lee (ACIP Chair)

Dr. Melinda Wharton (ACIP Executive Secretary, CDC)

8:10 Agency Updates

8:30 Combined Immunization Schedules

Introduction to 2024 adult and child/adolescent immunization 

schedule

2024 child and adolescent schedule revisions 

2024 adult schedule revisions 

Dr. Sybil Cineas (ACIP, WG Chair)

Dr. Patricia Wodi (CDC/NCIRD)

Dr. Neil Murthy (CDC/NCIRD)

9:50 Break

10:00 Public Comment

10:15 VOTES

Immunization Schedules Vote Dr. Patricia Wodi (CDC/NCIRD), Dr. Neil Murthy 

(CDC/NCIRD)

10:30 Chikungunya Vaccine

Introduction

EtR and proposed policy options for chikungunya vaccine use among 

U.S. adults traveling abroad 

EtR and proposed policy options for chikungunya vaccine use among 

laboratory workers

Dr. Beth Bell (ACIP, WG Chair)

Dr. Susan Hills (CDC/NCEZID)

Dr. Susan Hills (CDC/NCEZID)

11:40 Dengue Vaccines

Takeda dengue vaccine update Dr. Wilbur Chen (ACIP, WG Chair)

11:45 Break

12:00 COVID-19 Vaccines

Introduction

COVID-19 vaccine implementation

COVID-19 vaccine policy and next steps 

Dr. Matt Daley (ACIP, WG Chair)

Dr. Shannon Stokley (CDC/NCIRD)

Dr. Megan Wallace (CDC/NCIRD)

12:50 Pneumococcal Vaccines

Work Group Updates and Next Steps Dr. Miwako Kobayashi (CDC/NCIRD)

1:00 Influenza Vaccines

Effectiveness of maternal influenza vaccination during pregnancy 

against influenza-associated hospitalizations & emergency departme

visits in infants <6 Months of Age

Update on influenza B/Yamagata surveillance

nt 

Ms. Samantha Olson (CDC/NCIRD)

Dr. Rebecca Kondor (CDC/NCIRD)

1:40 Adjourn

Acronyms

CDC

CMS Centers for Medicare and Medicaid Services 

COVID-19 Coronavirus disease 2019

EtR Evidence to Recommendations Framework

FDA Food and Drug Administration

GRADE

HRSA Health Resources and Services Administration

IHS Indian Health Service

LAIV4 Live Attenuated Influenza Vaccine

NCHHSTP

NCIRD

NCEZID

NIAID

OIDP Office of Infectious Disease and HIV/AIDS Policy

SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2

WG Work Group

WHO World Health Organization

VE Vaccine Effectiveness

National Institute of Allergy and Infectious Diseases

Centers for Disease Control and Prevention

Grading of Recommendations Assessment, Development and Evaluation

National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID] 

National Center for Immunization & Respiratory Diseases [of CDC/OID] 

National Center for Emerging and Zoonotic Diseases [of CDC/OID]

Thursday, October 26, 2023